Legal Representation
Attorney
LORRIANE LINFORD
USPTO Deadlines
Application History
13 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Sep 19, 2001 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
Jan 24, 2001 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Nov 20, 2000 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Aug 15, 2000 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Jun 28, 2000 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Dec 28, 1999 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Oct 5, 1999 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Sep 3, 1999 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
May 21, 1999 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Apr 26, 1999 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Nov 2, 1998 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
Oct 23, 1998 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Oct 13, 1998 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
Genetic material, namely, single nucleotide polymorphisms or DNA fragments for clinical, diagnostic and therapeutic use for the treatment of cancer, autoimmune diseases, infectious diseases, inflammatory diseases and genetic diseases
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005